Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2007
05/09/2007EP1781371A2 Assay system for monitoring the effects of genetically engineered cells to alter function of a syncytium
05/09/2007EP1781338A2 Modulation of cytokine signaling regulators and applications for immunotherapy
05/09/2007EP1781318A2 Methods and compositions for the treatment of polycystic diseases
05/09/2007EP1599732B1 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-trp (mtr1 / ltrpc5 / trpm5)
05/09/2007EP1478759B1 Retroviral vectors pseudotyped with influenza virus hemagglutinin and influenza m2 potein for gene delivery
05/09/2007EP1313882B1 Diagnosis and treatment of prostate cancer
05/09/2007EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto
05/09/2007EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
05/09/2007EP1000149B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
05/09/2007EP0969720B1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
05/09/2007EP0853450B1 Compositions for the treatment of vascular injury
05/09/2007EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors
05/09/2007EP0692029B1 Genetically engineered glutaminase and its use in therapy
05/09/2007CN1961075A Therapeutic molecules for modulating stability of VEGF transcripts
05/09/2007CN1961073A Truncated DANCE, DANCE complex and method of using these
05/09/2007CN1960825A Functionalized colloidal metal compositions and methods
05/09/2007CN1960767A Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
05/09/2007CN1960707A Liposomal assembly for therapeutic and/or diagnostic use
05/09/2007CN1958803A Method for constructing genome integral recombined viral vector related to gland
05/09/2007CN1958801A Method for constructing interference plasmid of human fibrinogen hf12 shRNA, and pharmic usage
05/09/2007CN1958792A Method for obtaining inner morphine peptide, and application in center of treating pain
05/09/2007CN1958788A Gene recombined virus of human neurenergen 3
05/09/2007CN1958075A Compsn of anti-blood generating factor contg adeno-associated virus mediation and its application
05/09/2007CN1314811C Recombinant chimeric eucaryotic expression vector Cb1-Grb7(SH2)-RING and use of anti-tumour gene drug
05/09/2007CN1314808C Pyocyanine gene and target gene therapy of cancer with its packing and guiding protein composite
05/09/2007CN1314712C Preparation for fungus extracellular polysaccharide compound and application thereof
05/09/2007CN1314450C Multicomponent vaccines
05/08/2007USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof
05/08/2007US7214790 Genes and proteins encoded thereby
05/08/2007US7214782 Prognosis of neuroblastoma; antisense nucleic acids for malignant tumors
05/08/2007US7214774 Preparing and detecting antibodies by using the polypeptide as antigens, and selecting an antibody that specifically binds the polypeptide; developing drugs for the treatment of tumors.
05/08/2007US7214772 Sialoadhesin family member-2 (SAF-2)
05/08/2007US7214515 Viral delivery system for infectious transfer of large genomic DNA inserts
05/08/2007US7214495 Screening method
05/08/2007US7214483 KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies
05/08/2007US7214384 Lipid-conjugated polyamide compounds
05/08/2007US7214374 12832, a novel human kinase-like molecule and uses thereof
05/08/2007US7214369 applying pressure to mammalian skin around a limb using a sphygmomanometer and injecting a polynucleotide biodrug to promote angiogenesis
05/08/2007US7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene
05/08/2007CA2385872C Gene transfer in human lymphocytes using retroviral scfv cell targeting
05/08/2007CA2317690C Predicting survival of patients with squamous cell carcinoma
05/08/2007CA2302833C Peptides derived from the attachment (g) protein of respiratory syncytial virus
05/08/2007CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
05/08/2007CA2236968C Accessory functions for use in recombinant aav virion production
05/03/2007WO2007051045A2 Compositions and methods for inhibiting expression of huntingtin gene
05/03/2007WO2007050793A2 Methods and compositions for the treatment of marfan syndrome and associated disorders
05/03/2007WO2007050713A2 Blockade of calcium channels
05/03/2007WO2007050648A2 Use of tumor necrosis factor- receptor p75 for treatment of ischemia-induced neovascularization
05/03/2007WO2007050102A2 Dendritic cell based vaccines
05/03/2007WO2007050095A2 Improved vaccines and methods for using the same
05/03/2007WO2007050074A1 Conditionally replicating viruses and methods for cancer virotherapy
05/03/2007WO2007050059A2 Short immunolomodulatory oligonucleotides
05/03/2007WO2007050034A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
05/03/2007WO2007049752A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
05/03/2007WO2007049749A1 Therapeutic method for blood coagulation disorder
05/03/2007WO2007049737A1 Cytotoxic t-cell epitope peptide capable of specifically attacking cell infected with epstein-barr virus
05/03/2007WO2007049690A1 Formation/elongation of axon by inhibiting the expression or function of singar and application to nerve regeneration
05/03/2007WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same
05/03/2007WO2007049359A1 Method of controlling glucose metabolism
05/03/2007WO2007048413A1 IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF
05/03/2007WO2007048202A1 Methods and compositions for modulating wound repair
05/03/2007WO2007026236A3 Electrotransfer of nucleic acid into tissue cells
05/03/2007WO2006124626A3 Inhibition of the 44 kilodalton isoform of pim-1 kinase restores apoptosis induced by chemotherapeutic drugs in cancer cells
05/03/2007WO2006117250A3 Importation of mitochondrial protein by an enhanced allotopic approach
05/03/2007WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
05/03/2007WO2005091716A8 Annexin ii and uses thereof
05/03/2007US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
05/03/2007US20070101450 DNA that encodes a protein having high-affinity choline transporter activity
05/03/2007US20070099862 Sequence specific gene silencing; antisense agents
05/03/2007US20070099861 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
05/03/2007US20070099860 Double-stranded ribonucleic acid (dsRNA), mediating RNA interference, Huntington's disease
05/03/2007US20070099859 Phosphorus protecting groups
05/03/2007US20070099858 RNA interference mediated of inhibition of influenza virus gene expression using short interfering nucleic acid (siNA)
05/03/2007US20070099857 Methods and means for inhibiting fever
05/03/2007US20070099830 Sirt4 activities
05/03/2007US20070099275 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
05/03/2007US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness
05/03/2007US20070099270 Novel neurotrophic factors
05/03/2007US20070099255 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2(naaladase 2)
05/03/2007US20070099230 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor
05/03/2007US20070099215 NOVEL Bak BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF
05/03/2007US20070099176 Methods of expressing LIM mineralization protein
05/03/2007US20070098812 Annexin II and uses thereof
05/03/2007US20070098728 Novel compositions and methods in cancer
05/03/2007US20070098727 Use of cytokine expression to predict skin inflammation; methods of treatment
05/03/2007US20070098713 Nanoparticle delivery systems and methods of use thereof
05/03/2007US20070098704 Method of repairing tissue of a mammal
05/03/2007US20070098703 Methods for Using Adipose-Derived Cells for Healing of Aortic Aneurysmal Tissue
05/03/2007US20070098702 Recombinant protein polymer vectors for systemic gene delivery
05/03/2007US20070098701 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders
05/03/2007US20070098700 Synthetic mammalian retotransposon gene
05/03/2007US20070098692 Materials and methods for treating ocular-related disorders
05/03/2007US20070098691 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer
05/03/2007US20070098690 Truncated CMV promoters and vectors containing same
05/03/2007US20070098689 Mutant viruses
05/03/2007DE10333509B4 Gegen VEGF gerichtete Erkennungsmoleküle und die Verwendung dieser Directed against VEGF recognition molecules and the use of these
05/03/2007CA2665717A1 Methods and compositions comprising a flightless i antagonist for modulating wound repair
05/03/2007CA2627638A1 Conditionally replicating viruses and methods for cancer virotherapy
05/03/2007CA2627543A1 Implantable biocompatible immttnoisolatory vehicle for delivery of gdnf
05/03/2007CA2627485A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein